The human mitochondrial proteome: oxidative stress, protein modifications and oxidative phosphorylation.
暂无分享,去创建一个
[1] J S Beckman,et al. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.
[2] H. Forman,et al. Glutathione Depletion in PC12 Results in Selective Inhibition of Mitochondrial Complex I Activity , 2000, The Journal of Biological Chemistry.
[3] B. Robinson,et al. Control of oxygen free radical formation from mitochondrial complex I: roles for protein kinase A and pyruvate dehydrogenase kinase. , 2002, Free radical biology & medicine.
[4] D. Newmeyer,et al. Mitochondria Releasing Power for Life and Unleashing the Machineries of Death , 2003, Cell.
[5] R. Nussbaum,et al. Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.
[6] Mukesh Verma,et al. Proteomic analysis of cancer-cell mitochondria , 2003, Nature Reviews Cancer.
[7] R. Radi,et al. Peroxynitrite reactions and formation in mitochondria. , 2002, Free radical biology & medicine.
[8] Steven W. Taylor,et al. Oxidative Damage to Mitochondrial Complex I Due to Peroxynitrite , 2003, Journal of Biological Chemistry.
[9] Steven W. Taylor,et al. Global organellar proteomics. , 2003, Trends in biotechnology.
[10] Mark A. Wilson,et al. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[11] R. Aggeler,et al. Focused proteomics: Monoclonal antibody‐based isolation of the oxidative phosphorylation machinery and detection of phosphoproteins using a fluorescent phosphoprotein gel stain , 2004, Electrophoresis.
[12] S. Kornbluth,et al. Mitochondria at the Crossroad of Apoptotic Cell Death , 1999, Journal of bioenergetics and biomembranes.
[13] E. Stadtman,et al. Protein Oxidation in Aging and Age‐Related Diseases , 2001, Annals of the New York Academy of Sciences.
[14] Birgit Schilling,et al. Phosphospecific proteolysis for mapping sites of protein phosphorylation , 2003, Nature Biotechnology.
[15] P. Courchesne,et al. Two‐dimensional electrophoresis of human placental mitochondria and protein identification by mass spectrometry: Toward a human mitochondrial proteome , 1998, Electrophoresis.
[16] D. Wallace. Mitochondrial diseases in man and mouse. , 1999, Science.
[17] Jean-Claude Martinou,et al. Proteomic Analysis of the Mouse Liver Mitochondrial Inner Membrane* , 2003, Journal of Biological Chemistry.
[18] Bradford W. Gibson,et al. Characterization of the human heart mitochondrial proteome , 2003, Nature Biotechnology.
[19] Eoin Fahy,et al. Expanded coverage of the human heart mitochondrial proteome using multidimensional liquid chromatography coupled with tandem mass spectrometry. , 2004, Journal of proteome research.
[20] Robin A. J. Smith,et al. Mitochondria‐targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] Simon Melov,et al. Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice , 2003, Journal of neurochemistry.
[22] Jennifer E. Van Eyk,et al. Mitochondrial proteomics , 2003, Basic Research in Cardiology.
[23] Steven W. Taylor,et al. Oxidative Post-translational Modification of Tryptophan Residues in Cardiac Mitochondrial Proteins* , 2003, Journal of Biological Chemistry.
[24] George Oster,et al. Energy transduction in ATP synthase , 1998, Nature.
[25] B. Gibson,et al. Determining cysteine oxidation status using differential alkylation , 2004 .
[26] R. Aebersold,et al. The mitochondrial antioxidant defence system and its response to oxidative stress , 2001, Proteomics.
[27] I. Fearnley,et al. The Phosphorylation of Subunits of Complex I from Bovine Heart Mitochondria* , 2004, Journal of Biological Chemistry.
[28] K. Hensley,et al. Reactive oxygen species and protein oxidation in aging: a look back, a look ahead. , 2002, Archives of biochemistry and biophysics.
[29] Eoin Fahy,et al. MitoProteome: mitochondrial protein sequence database and annotation system , 2004, Nucleic Acids Res..
[30] J. Andersen,et al. Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO‐mediated pathway not involving peroxynitrite: implications for Parkinson's disease , 2005, Journal of neurochemistry.
[31] Gary Fiskum,et al. Regulation of hydrogen peroxide production by brain mitochondria by calcium and Bax , 2002, Journal of neurochemistry.
[32] S. Papa. The NDUFS4 nuclear gene of complex I of mitochondria and the cAMP cascade. , 2002, Biochimica et biophysica acta.
[33] Mary F. Lopez,et al. High‐throughput profiling of the mitochondrial proteome using affinity fractionation and automation , 2000, Electrophoresis.
[34] Thomas Meitinger,et al. MITOP, the mitochondrial proteome database: 2000 update , 2000, Nucleic Acids Res..
[35] Masasuke Yoshida,et al. The Rotary Machine in the Cell, ATP Synthase* 210 , 2001, The Journal of Biological Chemistry.
[36] E. R. Taylor,et al. Reversible Glutathionylation of Complex I Increases Mitochondrial Superoxide Formation* , 2003, Journal of Biological Chemistry.
[37] B. Gibson,et al. Two-dimensional electrophoresis and mass spectrometric identification of mitochondrial proteins from an SH-SY5Y neuroblastoma cell line. , 2001, Mitochondrion.
[38] P. Hogg,et al. Mitochondria as cancer drug targets. , 2004, Trends in molecular medicine.
[39] B. Robinson,et al. Mitochondria, oxygen free radicals, disease and ageing. , 2000, Trends in biochemical sciences.
[40] A. Szewczyk,et al. Mitochondria as a Pharmacological Target , 2002, Pharmacological Reviews.
[41] Marjan S. Bolouri,et al. Integrated Analysis of Protein Composition, Tissue Diversity, and Gene Regulation in Mouse Mitochondria , 2003, Cell.
[42] Wayne F. Patton,et al. Analysis of Steady-state Protein Phosphorylation in Mitochondria Using a Novel Fluorescent Phosphosensor Dye* , 2003, Journal of Biological Chemistry.
[43] P. Lescuyer,et al. Progress in the definition of a reference human mitochondrial proteome , 2003, Proteomics.
[44] C. F. Baxter,et al. Regulation of fatty acid β-oxidation in rat heart mitochondria , 1991 .
[45] Wayne F. Patton,et al. Characterization of dynamic and steady‐state protein phosphorylation using a fluorescent phosphoprotein gel stain and mass spectrometry , 2004, Electrophoresis.
[46] A. M. James,et al. Antioxidant and prooxidant properties of mitochondrial Coenzyme Q. , 2004, Archives of biochemistry and biophysics.
[47] S. Melov. Modeling mitochondrial function in aging neurons , 2004, Trends in Neurosciences.
[48] Robin A. J. Smith,et al. Drug delivery to mitochondria: the key to mitochondrial medicine. , 2000, Advanced drug delivery reviews.
[49] C. Marsden,et al. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia , 1994, Annals of neurology.
[50] Robin A. J. Smith,et al. Selective targeting of an antioxidant to mitochondria. , 1999, European journal of biochemistry.
[51] Steven W. Taylor,et al. An alternative strategy to determine the mitochondrial proteome using sucrose gradient fractionation and 1D PAGE on highly purified human heart mitochondria. , 2002, Journal of proteome research.
[52] I. Summerhayes,et al. Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[53] S. Melov,et al. Extension of life-span with superoxide dismutase/catalase mimetics. , 2000, Science.